| scholarly article | Q13442814 |
| P50 | author | Simon Cauchemez | Q28152057 |
| Frederick G Hayden | Q87843428 | ||
| P2093 | author name string | David Evans | |
| P2860 | cites work | Guillain-Barré syndrome | Q24276200 |
| Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans | Q28297557 | ||
| Preparing for avian influenza: lessons from the "swine flu affair". | Q30229020 | ||
| Reflections on the 1976 swine flu vaccination program. | Q30353066 | ||
| Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. | Q30367585 | ||
| Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. | Q30373486 | ||
| Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. | Q30376061 | ||
| Pandemic influenza: confronting a re-emergent threat. The 1976 experience | Q30427961 | ||
| Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. | Q33280997 | ||
| Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977 | Q34215590 | ||
| Guillain-Barré syndrome following influenza vaccination | Q34370829 | ||
| Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome | Q34784351 | ||
| Guillain-Barré syndrome and influenza virus infection | Q34885906 | ||
| Control without separate controls: evaluation of vaccine safety using case-only methods | Q35762066 | ||
| Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. | Q41890248 | ||
| Influenza vaccination and Guillain Barre syndrome | Q44451428 | ||
| Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system | Q44998783 | ||
| Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions | Q45399390 | ||
| Economic cost of Guillain-Barré syndrome in the United States | Q45769845 | ||
| Measles vaccination and Guillain-Barré syndrome. | Q50619044 | ||
| The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. | Q50852734 | ||
| Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). | Q51789015 | ||
| Guillain-Barré Syndrome After Influenza Vaccination in Adults | Q57661024 | ||
| Re: "Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988" | Q67566863 | ||
| Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System | Q80460185 | ||
| Real-time vaccine safety surveillance for the early detection of adverse events | Q81382227 | ||
| Adverse events reported following live, cold-adapted, intranasal influenza vaccine | Q81584027 | ||
| Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2008 | Q83569868 | ||
| Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period | Q84062766 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Guillain–Barré syndrome | Q205214 |
| immunization | Q1415366 | ||
| P304 | page(s) | 321-328 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events | |
| P478 | volume | 200 |
| Q30413197 | Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus |
| Q34024573 | Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome? |
| Q51369030 | Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases. |
| Q30389582 | Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks |
| Q55058719 | Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA). |
| Q30372042 | Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus. |
| Q30380974 | Economic analysis of pandemic influenza vaccination strategies in Singapore. |
| Q30383451 | Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic |
| Q30227043 | Emerging, novel, and known influenza virus infections in humans. |
| Q52593678 | Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs. |
| Q30415924 | Guillain-Barré syndrome after exposure to influenza |
| Q28291850 | Guillain-Barré syndrome after exposure to influenza virus |
| Q30389390 | Guillain-Barré syndrome following H1N1 immunization in a pediatric patient |
| Q40607323 | HLA-DRB1 the notorious gene in the mosaic of autoimmunity |
| Q30364375 | Healthcare workers under a mandated H1N1 vaccination policy with employment termination penalty: a survey to assess employee perception. |
| Q43203710 | High incidence of Guillain-Barre syndrome in children, Bangladesh |
| Q37878862 | Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections. |
| Q30409462 | Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes |
| Q30423370 | Influenza-associated neurological complications |
| Q82552265 | Neurological infections: the year of PML and influenza |
| Q30407561 | No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies |
| Q34499848 | Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines |
| Q30587338 | Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines |
| Q30385094 | Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? |
| Q30397714 | Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010. |
| Q37823382 | Surveillance of adverse effects following vaccination and safety of immunization programs |
| Q84104357 | Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial |
| Q30403785 | Vaccination of health-care workers against influenza: our obligation to protect patients |
| Q34117134 | Vaccinations in patients with immune-mediated inflammatory diseases |
| Q82234692 | WITHDRAWN: Revista Portuguesa de Pneumologia: Ano em Revisão 2010 |
Search more.